Cytokinetics, Incorporated (CYTK) Stock

Cytokinetics, Incorporated (CYTK) is a Healthcare stock trading at $78.68 (as of 2026-06-18), with a market capitalization of $9.55B and a trailing P/E of -10.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Cytokinetics develops and commercializes small-molecule therapies intended to affect muscle function, including muscle activators and inhibitors. Its pipeline includes cardiac and skeletal muscle candidates such as omecamtiv mecarbil and reldesemtiv, with additional programs in clinical stages for conditions including heart failure, amyotrophic lateral sclerosis, spinal muscular atrophy, and hypertrophic cardiomyopathy.

Valuation — source: SEC EDGAR (first-party)
Price$78.68
Market Cap$9.55B
P/E Ratio-10.2
EV / EBITDA-14.1
Price / Book-10.56
Price / Sales82.49
DCF Value (model)$-75.24
DCF Upside vs Price-195.6%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$88.04M
Net Margin-891.6%
Return on Equity100.4%
Debt / Equity-0.35
Current Ratio4.21
Revenue Growth (YoY)376.6%
EPS Growth (YoY)24.3%
FCF Growth (YoY)33.8%
Financial Health — source: SEC EDGAR
Altman Z-Score-1.39 (distress)
Valuation vs Sector & Industry
Stock P/E-10.2
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-148.9%
vs Industry-159.3%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderT. Rowe Price Investment Management, Inc. ($1.15B)
Institutional Holders Tracked10
Congressional Trades (recent)3
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORobert I. Blum
Employees498
CountryUS
IPO Date2004-04-30

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Qiagen N.V. (QGEN)
  • Axsome Therapeutics, Inc. (AXSM)
  • Halozyme Therapeutics, Inc. (HALO)
  • Praxis Precision Medicines, Inc. (PRAX)
  • Nuvalent, Inc. (NUVL)
  • Krystal Biotech, Inc. (KRYS)
  • Rhythm Pharmaceuticals, Inc. (RYTM)
  • Kymera Therapeutics, Inc. (KYMR)
CYTK earnings history · CYTK institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.